Accuray receives FDA 510(k) clearance for CyberKnife M6 Series
Accuray received FDA 510(k) clearance for the CyberKnife M6 Series robotic radiosurgery system.
Evidence notes
- The FDA clearance covered the CyberKnife M6 Series.
- The system added the InCise Multileaf Collimator to robotic radiosurgery workflows.
- Accuray said the clearance broadened CyberKnife treatment applications and improved efficiency.
Company context
Accuray develops and manufactures robotic radiosurgery and image-guided radiation therapy systems, including the CyberKnife and helical TomoTherapy and Radixact platforms.